{
  "disease_name": "Mucopolysaccharidosis type 3",
  "orpha_code": "581",
  "drugs": [
    {
      "name": "Trehalose",
      "substance_url": "/en/drug/substance/418127?name=581&mode=orpha&region=&status=all",
      "substance_id": "418127",
      "regulatory_url": "/en/drug/regulatory/604845?name=581&mode=orpha&region=",
      "regulatory_id": "604845",
      "orpha_substance_code": "ORPHA:581",
      "details": [
        "Trehalose(Medicinal product                        - 21/08/2020)Disease(s) concernedORPHA:581 Mucopolysaccharidosis type 3",
        "Trehalose(Medicinal product                        - 21/08/2020)",
        "(Medicinal product                        - 21/08/2020)",
        "Disease(s) concernedORPHA:581 Mucopolysaccharidosis type 3",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/418127?name=581&mode=orpha&region=&status=all",
          "text": "Trehalose",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/581",
          "text": "ORPHA:581 Mucopolysaccharidosis type 3",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604845?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Genistein sodium salt dihydrate",
      "substance_url": "/en/drug/substance/299549?name=581&mode=orpha&region=&status=all",
      "substance_id": "299549",
      "regulatory_url": "/en/drug/regulatory/301149?name=581&mode=orpha&region=",
      "regulatory_id": "301149",
      "orpha_substance_code": "ORPHA:581",
      "details": [
        "Genistein sodium salt dihydrate(Medicinal product                        - 02/04/2012)Disease(s) concernedORPHA:581 Mucopolysaccharidosis type 3",
        "Genistein sodium salt dihydrate(Medicinal product                        - 02/04/2012)",
        "(Medicinal product                        - 02/04/2012)",
        "Disease(s) concernedORPHA:581 Mucopolysaccharidosis type 3",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/299549?name=581&mode=orpha&region=&status=all",
          "text": "Genistein sodium salt dihydrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/581",
          "text": "ORPHA:581 Mucopolysaccharidosis type 3",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/301149?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human heparan-N-sulfatase",
      "substance_url": "/en/drug/substance/165346?name=581&mode=orpha&region=&status=all",
      "substance_id": "165346",
      "regulatory_url": "/en/drug/regulatory/661148?name=581&mode=orpha&region=",
      "regulatory_id": "661148",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Recombinant human heparan-N-sulfatase(Medicinal product                        - 12/01/2024)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Recombinant human heparan-N-sulfatase(Medicinal product                        - 12/01/2024)",
        "(Medicinal product                        - 12/01/2024)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/165346?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant human heparan-N-sulfatase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661148?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting the human transferrin receptor",
      "substance_url": "/en/drug/substance/628237?name=581&mode=orpha&region=&status=all",
      "substance_id": "628237",
      "regulatory_url": "/en/drug/regulatory/628238?name=581&mode=orpha&region=",
      "regulatory_id": "628238",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting the human transferrin receptor(Medicinal product                        - 14/01/2022)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting the human transferrin receptor(Medicinal product                        - 14/01/2022)",
        "(Medicinal product                        - 14/01/2022)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/628237?name=581&mode=orpha&region=&status=all",
          "text": "N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting the human transferrin receptor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/628238?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant adeno-associated viral vector serotype 9 containing the human N-alpha-acetylglucosaminidase gene",
      "substance_url": "/en/drug/substance/531913?name=581&mode=orpha&region=&status=all",
      "substance_id": "531913",
      "regulatory_url": "/en/drug/regulatory/531914?name=581&mode=orpha&region=",
      "regulatory_id": "531914",
      "orpha_substance_code": "ORPHA:79270",
      "details": [
        "Recombinant adeno-associated viral vector serotype 9 containing the human N-alpha-acetylglucosaminidase gene(Medicinal product                        - 12/01/2017)Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "Recombinant adeno-associated viral vector serotype 9 containing the human N-alpha-acetylglucosaminidase gene(Medicinal product                        - 12/01/2017)",
        "(Medicinal product                        - 12/01/2017)",
        "Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/531913?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant adeno-associated viral vector serotype 9 containing the human N-alpha-acetylglucosaminidase gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79270",
          "text": "ORPHA:79270 Sanfilippo syndrome type B",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/531914?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type B\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Chemically modified human recombinant sulfamidase",
      "substance_url": "/en/drug/substance/484789?name=581&mode=orpha&region=&status=all",
      "substance_id": "484789",
      "regulatory_url": "/en/drug/regulatory/484790?name=581&mode=orpha&region=",
      "regulatory_id": "484790",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Chemically modified human recombinant sulfamidase(Medicinal product                        - 14/10/2016)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Chemically modified human recombinant sulfamidase(Medicinal product                        - 14/10/2016)",
        "(Medicinal product                        - 14/10/2016)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/484789?name=581&mode=orpha&region=&status=all",
          "text": "Chemically modified human recombinant sulfamidase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/484790?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Self-complementary adeno-associated viral vector serotype 9 containing the SGSH gene",
      "substance_url": "/en/drug/substance/484726?name=581&mode=orpha&region=&status=all",
      "substance_id": "484726",
      "regulatory_url": "/en/drug/regulatory/484745?name=581&mode=orpha&region=",
      "regulatory_id": "484745",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Self-complementary adeno-associated viral vector serotype 9 containing the SGSH gene(Medicinal product                        - 20/09/2016)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Self-complementary adeno-associated viral vector serotype 9 containing the SGSH gene(Medicinal product                        - 20/09/2016)",
        "(Medicinal product                        - 20/09/2016)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/484726?name=581&mode=orpha&region=&status=all",
          "text": "Self-complementary adeno-associated viral vector serotype 9 containing the SGSH gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/484745?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "adeno-associated viral vector serotype 9 containing the human HGSNAT gene",
      "substance_url": "/en/drug/substance/444449?name=581&mode=orpha&region=&status=all",
      "substance_id": "444449",
      "regulatory_url": "/en/drug/regulatory/444451?name=581&mode=orpha&region=",
      "regulatory_id": "444451",
      "orpha_substance_code": "ORPHA:79271",
      "details": [
        "adeno-associated viral vector serotype 9 containing the human HGSNAT gene(Medicinal product                        - 21/05/2015)Disease(s) concernedORPHA:79271 Sanfilippo syndrome type C",
        "adeno-associated viral vector serotype 9 containing the human HGSNAT gene(Medicinal product                        - 21/05/2015)",
        "(Medicinal product                        - 21/05/2015)",
        "Disease(s) concernedORPHA:79271 Sanfilippo syndrome type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/444449?name=581&mode=orpha&region=&status=all",
          "text": "adeno-associated viral vector serotype 9 containing the human HGSNAT gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79271",
          "text": "ORPHA:79271 Sanfilippo syndrome type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/444451?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2",
      "substance_url": "/en/drug/substance/418092?name=581&mode=orpha&region=&status=all",
      "substance_id": "418092",
      "regulatory_url": "/en/drug/regulatory/437343?name=581&mode=orpha&region=",
      "regulatory_id": "437343",
      "orpha_substance_code": "ORPHA:79270",
      "details": [
        "Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2(Medicinal product                        - 15/01/2015)Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2(Medicinal product                        - 15/01/2015)",
        "(Medicinal product                        - 15/01/2015)",
        "Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/418092?name=581&mode=orpha&region=&status=all",
          "text": "Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79270",
          "text": "ORPHA:79270 Sanfilippo syndrome type B",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/437343?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type B\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype rh.10 carrying the human N-sulfoglucosamine sulfohydrolase cDNA",
      "substance_url": "/en/drug/substance/414082?name=581&mode=orpha&region=&status=all",
      "substance_id": "414082",
      "regulatory_url": "/en/drug/regulatory/437406?name=581&mode=orpha&region=",
      "regulatory_id": "437406",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Adeno-associated viral vector serotype rh.10 carrying the human N-sulfoglucosamine sulfohydrolase cDNA(Medicinal product                        - 16/12/2014)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Adeno-associated viral vector serotype rh.10 carrying the human N-sulfoglucosamine sulfohydrolase cDNA(Medicinal product                        - 16/12/2014)",
        "(Medicinal product                        - 16/12/2014)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/414082?name=581&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype rh.10 carrying the human N-sulfoglucosamine sulfohydrolase cDNA",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/437406?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene",
      "substance_url": "/en/drug/substance/399640?name=581&mode=orpha&region=&status=all",
      "substance_id": "399640",
      "regulatory_url": "/en/drug/regulatory/406120?name=581&mode=orpha&region=",
      "regulatory_id": "406120",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene(Medicinal product                        - 10/06/2014)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene(Medicinal product                        - 10/06/2014)",
        "(Medicinal product                        - 10/06/2014)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/399640?name=581&mode=orpha&region=&status=all",
          "text": "Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/406120?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector containing the human alpha-N-acetylglucosaminidase gene",
      "substance_url": "/en/drug/substance/275655?name=581&mode=orpha&region=&status=all",
      "substance_id": "275655",
      "regulatory_url": "/en/drug/regulatory/286416?name=581&mode=orpha&region=",
      "regulatory_id": "286416",
      "orpha_substance_code": "ORPHA:79270",
      "details": [
        "Adeno-associated viral vector containing the human alpha-N-acetylglucosaminidase gene(Medicinal product                        - 27/10/2011)Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "Adeno-associated viral vector containing the human alpha-N-acetylglucosaminidase gene(Medicinal product                        - 27/10/2011)",
        "(Medicinal product                        - 27/10/2011)",
        "Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/275655?name=581&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector containing the human alpha-N-acetylglucosaminidase gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79270",
          "text": "ORPHA:79270 Sanfilippo syndrome type B",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/286416?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type B\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 9 containing the human sulfamidase gene",
      "substance_url": "/en/drug/substance/260412?name=581&mode=orpha&region=&status=all",
      "substance_id": "260412",
      "regulatory_url": "/en/drug/regulatory/275275?name=581&mode=orpha&region=",
      "regulatory_id": "275275",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Adeno-associated viral vector serotype 9 containing the human sulfamidase gene(Medicinal product                        - 21/06/2011)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Adeno-associated viral vector serotype 9 containing the human sulfamidase gene(Medicinal product                        - 21/06/2011)",
        "(Medicinal product                        - 21/06/2011)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/260412?name=581&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 containing the human sulfamidase gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/275275?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs",
      "substance_url": "/en/drug/substance/230772?name=581&mode=orpha&region=&status=all",
      "substance_id": "230772",
      "regulatory_url": "/en/drug/regulatory/246930?name=581&mode=orpha&region=",
      "regulatory_id": "246930",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs(Medicinal product                        - 20/09/2010)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs(Medicinal product                        - 20/09/2010)",
        "(Medicinal product                        - 20/09/2010)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/230772?name=581&mode=orpha&region=&status=all",
          "text": "Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/246930?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human alpha-N-acetylglucosaminidase",
      "substance_url": "/en/drug/substance/332867?name=581&mode=orpha&region=&status=all",
      "substance_id": "332867",
      "regulatory_url": "/en/drug/regulatory/359498?name=581&mode=orpha&region=",
      "regulatory_id": "359498",
      "orpha_substance_code": "ORPHA:79270",
      "details": [
        "Recombinant human alpha-N-acetylglucosaminidase(Medicinal product                        - 19/06/2013)Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "Recombinant human alpha-N-acetylglucosaminidase(Medicinal product                        - 19/06/2013)",
        "(Medicinal product                        - 19/06/2013)",
        "Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/332867?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant human alpha-N-acetylglucosaminidase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79270",
          "text": "ORPHA:79270 Sanfilippo syndrome type B",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/359498?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type B\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 9 containing the human N-acetylglucosaminidase alpha gene",
      "substance_url": "/en/drug/substance/321495?name=581&mode=orpha&region=&status=all",
      "substance_id": "321495",
      "regulatory_url": "/en/drug/regulatory/323618?name=581&mode=orpha&region=",
      "regulatory_id": "323618",
      "orpha_substance_code": "ORPHA:79270",
      "details": [
        "Adeno-associated viral vector serotype 9 containing the human N-acetylglucosaminidase alpha gene(Medicinal product                        - 24/01/2013)Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "Adeno-associated viral vector serotype 9 containing the human N-acetylglucosaminidase alpha gene(Medicinal product                        - 24/01/2013)",
        "(Medicinal product                        - 24/01/2013)",
        "Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/321495?name=581&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 containing the human N-acetylglucosaminidase alpha gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79270",
          "text": "ORPHA:79270 Sanfilippo syndrome type B",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/323618?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type B\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human heparan-N-sulfatase",
      "substance_url": "/en/drug/substance/165346?name=581&mode=orpha&region=&status=all",
      "substance_id": "165346",
      "regulatory_url": "/en/drug/regulatory/165347?name=581&mode=orpha&region=",
      "regulatory_id": "165347",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Recombinant human heparan-N-sulfatase(Medicinal product                        - 07/11/2008)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Recombinant human heparan-N-sulfatase(Medicinal product                        - 07/11/2008)",
        "(Medicinal product                        - 07/11/2008)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/165346?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant human heparan-N-sulfatase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/165347?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant glycoprotein consisting of modified human alpha-N-acetylglucosaminidase (mhNAGLU) and a humanized antibody that specifically recognizes hTfR",
      "substance_url": "/en/drug/substance/699865?name=581&mode=orpha&region=&status=all",
      "substance_id": "699865",
      "regulatory_url": "/en/drug/regulatory/700142?name=581&mode=orpha&region=",
      "regulatory_id": "700142",
      "orpha_substance_code": "ORPHA:79270",
      "details": [
        "Recombinant glycoprotein consisting of modified human alpha-N-acetylglucosaminidase (mhNAGLU) and a humanized antibody that specifically recognizes hTfR(Medicinal product                        - 25/04/2025)Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "Recombinant glycoprotein consisting of modified human alpha-N-acetylglucosaminidase (mhNAGLU) and a humanized antibody that specifically recognizes hTfR(Medicinal product                        - 25/04/2025)",
        "(Medicinal product                        - 25/04/2025)",
        "Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/699865?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant glycoprotein consisting of modified human alpha-N-acetylglucosaminidase (mhNAGLU) and a humanized antibody that specifically recognizes hTfR",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79270",
          "text": "ORPHA:79270 Sanfilippo syndrome type B",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/700142?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type B\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "N-sulfoglucosamine sulfohydrolase",
      "substance_url": "/en/drug/substance/662636?name=581&mode=orpha&region=&status=all",
      "substance_id": "662636",
      "regulatory_url": "/en/drug/regulatory/662828?name=581&mode=orpha&region=",
      "regulatory_id": "662828",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "N-sulfoglucosamine sulfohydrolase(Medicinal product                        - 20/02/2024)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "N-sulfoglucosamine sulfohydrolase(Medicinal product                        - 20/02/2024)",
        "(Medicinal product                        - 20/02/2024)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/662636?name=581&mode=orpha&region=&status=all",
          "text": "N-sulfoglucosamine sulfohydrolase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/662828?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human N-acetylglucosamine-6-sulfatase enzyme (rhGNS)",
      "substance_url": "/en/drug/substance/663169?name=581&mode=orpha&region=&status=all",
      "substance_id": "663169",
      "regulatory_url": "/en/drug/regulatory/663252?name=581&mode=orpha&region=",
      "regulatory_id": "663252",
      "orpha_substance_code": "ORPHA:79272",
      "details": [
        "Recombinant human N-acetylglucosamine-6-sulfatase enzyme (rhGNS)(Medicinal product                        - 16/01/2024)Disease(s) concernedORPHA:79272 Sanfilippo syndrome type D",
        "Recombinant human N-acetylglucosamine-6-sulfatase enzyme (rhGNS)(Medicinal product                        - 16/01/2024)",
        "(Medicinal product                        - 16/01/2024)",
        "Disease(s) concernedORPHA:79272 Sanfilippo syndrome type D",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/663169?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant human N-acetylglucosamine-6-sulfatase enzyme (rhGNS)",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79272",
          "text": "ORPHA:79272 Sanfilippo syndrome type D",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/663252?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type D\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Human N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting human transferrin receptor",
      "substance_url": "/en/drug/substance/664315?name=581&mode=orpha&region=&status=all",
      "substance_id": "664315",
      "regulatory_url": "/en/drug/regulatory/664317?name=581&mode=orpha&region=",
      "regulatory_id": "664317",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Human N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting human transferrin receptor(Medicinal product                        - 12/12/2023)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Human N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting human transferrin receptor(Medicinal product                        - 12/12/2023)",
        "(Medicinal product                        - 12/12/2023)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/664315?name=581&mode=orpha&region=&status=all",
          "text": "Human N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting human transferrin receptor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/664317?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant adeno-associated virus serotype 9 vector containing the codon optimized human alpha-N-acetylglucosaminidase (NAGLU) gene",
      "substance_url": "/en/drug/substance/666378?name=581&mode=orpha&region=&status=all",
      "substance_id": "666378",
      "regulatory_url": "/en/drug/regulatory/666429?name=581&mode=orpha&region=",
      "regulatory_id": "666429",
      "orpha_substance_code": "ORPHA:79270",
      "details": [
        "Recombinant adeno-associated virus serotype 9 vector containing the codon optimized human alpha-N-acetylglucosaminidase (NAGLU) gene(Medicinal product                        - 01/08/2023)Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "Recombinant adeno-associated virus serotype 9 vector containing the codon optimized human alpha-N-acetylglucosaminidase (NAGLU) gene(Medicinal product                        - 01/08/2023)",
        "(Medicinal product                        - 01/08/2023)",
        "Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/666378?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant adeno-associated virus serotype 9 vector containing the codon optimized human alpha-N-acetylglucosaminidase (NAGLU) gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79270",
          "text": "ORPHA:79270 Sanfilippo syndrome type B",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/666429?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type B\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant self-complementary adeno-associated virus9 gene therapy expressing codon-optimized human N-Sulfoglucosamine Sulfohydrolase gene",
      "substance_url": "/en/drug/substance/646592?name=581&mode=orpha&region=&status=all",
      "substance_id": "646592",
      "regulatory_url": "/en/drug/regulatory/646689?name=581&mode=orpha&region=",
      "regulatory_id": "646689",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Recombinant self-complementary adeno-associated virus9 gene therapy expressing codon-optimized human N-Sulfoglucosamine Sulfohydrolase gene(Medicinal product                        - 26/04/2023)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Recombinant self-complementary adeno-associated virus9 gene therapy expressing codon-optimized human N-Sulfoglucosamine Sulfohydrolase gene(Medicinal product                        - 26/04/2023)",
        "(Medicinal product                        - 26/04/2023)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/646592?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant self-complementary adeno-associated virus9 gene therapy expressing codon-optimized human N-Sulfoglucosamine Sulfohydrolase gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/646689?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human heparan-N-sulfatase",
      "substance_url": "/en/drug/substance/165346?name=581&mode=orpha&region=&status=all",
      "substance_id": "165346",
      "regulatory_url": "/en/drug/regulatory/641312?name=581&mode=orpha&region=",
      "regulatory_id": "641312",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Recombinant human heparan-N-sulfatase(Medicinal product                        - 24/01/2023)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Recombinant human heparan-N-sulfatase(Medicinal product                        - 24/01/2023)",
        "(Medicinal product                        - 24/01/2023)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/165346?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant human heparan-N-sulfatase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/641312?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2",
      "substance_url": "/en/drug/substance/418092?name=581&mode=orpha&region=&status=all",
      "substance_id": "418092",
      "regulatory_url": "/en/drug/regulatory/418093?name=581&mode=orpha&region=",
      "regulatory_id": "418093",
      "orpha_substance_code": "ORPHA:79270",
      "details": [
        "Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2(Medicinal product                        - 25/11/2014)Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2(Medicinal product                        - 25/11/2014)",
        "(Medicinal product                        - 25/11/2014)",
        "Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/418092?name=581&mode=orpha&region=&status=all",
          "text": "Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79270",
          "text": "ORPHA:79270 Sanfilippo syndrome type B",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/418093?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type B\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant AAV9 expressing human alpha-N-acetylglucosaminidase",
      "substance_url": "/en/drug/substance/404220?name=581&mode=orpha&region=&status=all",
      "substance_id": "404220",
      "regulatory_url": "/en/drug/regulatory/404221?name=581&mode=orpha&region=",
      "regulatory_id": "404221",
      "orpha_substance_code": "ORPHA:79270",
      "details": [
        "Recombinant AAV9 expressing human alpha-N-acetylglucosaminidase(Medicinal product                        - 30/04/2014)Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "Recombinant AAV9 expressing human alpha-N-acetylglucosaminidase(Medicinal product                        - 30/04/2014)",
        "(Medicinal product                        - 30/04/2014)",
        "Disease(s) concernedORPHA:79270 Sanfilippo syndrome type B",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/404220?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant AAV9 expressing human alpha-N-acetylglucosaminidase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79270",
          "text": "ORPHA:79270 Sanfilippo syndrome type B",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/404221?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type B\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant AAV9 expressing human sulfoglucosamine sulfohydrolase",
      "substance_url": "/en/drug/substance/404267?name=581&mode=orpha&region=&status=all",
      "substance_id": "404267",
      "regulatory_url": "/en/drug/regulatory/405616?name=581&mode=orpha&region=",
      "regulatory_id": "405616",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Recombinant AAV9 expressing human sulfoglucosamine sulfohydrolase(Medicinal product                        - 29/04/2014)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Recombinant AAV9 expressing human sulfoglucosamine sulfohydrolase(Medicinal product                        - 29/04/2014)",
        "(Medicinal product                        - 29/04/2014)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/404267?name=581&mode=orpha&region=&status=all",
          "text": "Recombinant AAV9 expressing human sulfoglucosamine sulfohydrolase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/405616?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs",
      "substance_url": "/en/drug/substance/230772?name=581&mode=orpha&region=&status=all",
      "substance_id": "230772",
      "regulatory_url": "/en/drug/regulatory/357683?name=581&mode=orpha&region=",
      "regulatory_id": "357683",
      "orpha_substance_code": "ORPHA:79269",
      "details": [
        "Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs(Medicinal product                        - 05/06/2013)Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs(Medicinal product                        - 05/06/2013)",
        "(Medicinal product                        - 05/06/2013)",
        "Disease(s) concernedORPHA:79269 Sanfilippo syndrome type A",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/230772?name=581&mode=orpha&region=&status=all",
          "text": "Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79269",
          "text": "ORPHA:79269 Sanfilippo syndrome type A",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/357683?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type A\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "PLERIXAFOR ACCORD",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/642317?name=581&mode=orpha&region=",
      "regulatory_id": "642317",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "PLERIXAFOR ACCORD(Tradename                        - 16/12/2022)Disease(s) concernedORPHA:29073 Multiple myelomaORPHA:223735 LymphomaORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "PLERIXAFOR ACCORD(Tradename                        - 16/12/2022)",
        "(Tradename                        - 16/12/2022)",
        "Disease(s) concernedORPHA:29073 Multiple myelomaORPHA:223735 LymphomaORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/642316?name=581&mode=orpha&region=&status=all",
          "text": "PLERIXAFOR ACCORD",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/29073",
          "text": "ORPHA:29073 Multiple myeloma",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/223735",
          "text": "ORPHA:223735 Lymphoma",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/642317?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Thiotepa Riemser",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/610636?name=581&mode=orpha&region=",
      "regulatory_id": "610636",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Thiotepa Riemser(Tradename                        - 26/03/2021)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Thiotepa Riemser(Tradename                        - 26/03/2021)",
        "(Tradename                        - 26/03/2021)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/610616?name=581&mode=orpha&region=&status=all",
          "text": "Thiotepa Riemser",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/610636?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "motixafortide",
      "substance_url": "/en/drug/substance/588874?name=581&mode=orpha&region=&status=all",
      "substance_id": "588874",
      "regulatory_url": "/en/drug/regulatory/661036?name=581&mode=orpha&region=",
      "regulatory_id": "661036",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "motixafortide(Medicinal product                        - 12/01/2024)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "motixafortide(Medicinal product                        - 12/01/2024)",
        "(Medicinal product                        - 12/01/2024)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/588874?name=581&mode=orpha&region=&status=all",
          "text": "motixafortide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661036?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate",
      "substance_url": "/en/drug/substance/589233?name=581&mode=orpha&region=&status=all",
      "substance_id": "589233",
      "regulatory_url": "/en/drug/regulatory/589234?name=581&mode=orpha&region=",
      "regulatory_id": "589234",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate(Medicinal product                        - 20/04/2020)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate(Medicinal product                        - 20/04/2020)",
        "(Medicinal product                        - 20/04/2020)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/589233?name=581&mode=orpha&region=&status=all",
          "text": "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/589234?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus",
      "substance_url": "/en/drug/substance/589056?name=581&mode=orpha&region=&status=all",
      "substance_id": "589056",
      "regulatory_url": "/en/drug/regulatory/589057?name=581&mode=orpha&region=",
      "regulatory_id": "589057",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus(Medicinal product                        - 24/03/2020)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus(Medicinal product                        - 24/03/2020)",
        "(Medicinal product                        - 24/03/2020)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/589056?name=581&mode=orpha&region=&status=all",
          "text": "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/589057?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=581&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=581&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=581&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Besilesomab",
      "substance_url": "/en/drug/substance/571152?name=581&mode=orpha&region=&status=all",
      "substance_id": "571152",
      "regulatory_url": "/en/drug/regulatory/641081?name=581&mode=orpha&region=",
      "regulatory_id": "641081",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Besilesomab(Medicinal product                        - 28/03/2022)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Besilesomab(Medicinal product                        - 28/03/2022)",
        "(Medicinal product                        - 28/03/2022)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/571152?name=581&mode=orpha&region=&status=all",
          "text": "Besilesomab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/641081?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Besilesomab",
      "substance_url": "/en/drug/substance/571152?name=581&mode=orpha&region=&status=all",
      "substance_id": "571152",
      "regulatory_url": "/en/drug/regulatory/641075?name=581&mode=orpha&region=",
      "regulatory_id": "641075",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Besilesomab(Medicinal product                        - 28/03/2022)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Besilesomab(Medicinal product                        - 28/03/2022)",
        "(Medicinal product                        - 28/03/2022)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/571152?name=581&mode=orpha&region=&status=all",
          "text": "Besilesomab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/641075?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=581&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=581&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=581&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=581&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=581&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=581&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=581&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T05:55:40.397885",
  "run_number": 1,
  "total_drugs_found": 38,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Mucopolysaccharidosis+type+3&orphaCode=581&name=581&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Mucopolysaccharidosis type 3",
    "orphaCode": "581",
    "name": "581",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}